When infected pancreatic necrosis is diagnosed in a patient who is clinically stable — without hemodynamic compromise or systemic deterioration — proceeding directly to drainage or surgery is not the current standard of care. The sequence of management in this scenario matters significantly.
Infected pancreatic necrosis with no hemodynamic or clinical instability. Current consensus reserves early surgery for patients who are clinically unstable. For clinically stable patients, the initial approach focuses on giving the necrosis time to organise before any invasive intervention.
The initial strategy centres on antibiotic agents chosen for their ability to penetrate the necrotic pancreatic tissue, administered for a defined period before any drainage is considered. In a subset of patients, this approach alone may lead to full resolution — avoiding the need for drainage altogether. The complete agent selection criteria, sequencing, and decision framework are in the full protocol.
Resolution of infection of the pancreatic necrosis.
Current consensus is that surgery should be performed on clinically unstable patients with infected necrosis.
However, in most patients, those clinically stable, the initial management of infected necrosis should be a 30-day course of antibiotics before surgery to allow the inflammatory reaction to become better organized.
In patients with infected necrosis, antibiotics known to penetrate pancreatic necrosis should be used largely to delay surgical, endoscopic, and radiologic drainage beyond 4 weeks.
Some patients may avoid drainage altogether because the infection may completely resolve with antibiotics.
Current consensus is that the initial management of infected necrosis for patients who are clinically stable should be a 2- to 4-week course of antibiotics before surgery to allow the inflammatory reaction to become better organized.
View source ↗